My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Deep Industries drops after recent sharp rally
Jun 19,2017

Meanwhile, the S&P BSE Sensex was up 159.99 points, or 0.52% at 31,216.39. The S&P BSE Small-Cap index was up 11.76 points, or 0.08% at 15,679.

On the BSE, 8,296 shares were traded on the counter so far as against the average daily volumes of 1.81 lakh shares in the past one quarter. The stock had hit a high of Rs 310.90 and a low of Rs 296.15 so far during the day. The stock had hit a record high of Rs 343.70 on 30 March 2017 and a 52-week low of Rs 162.05 on 24 June 2016.

The stock had underperformed the market over the past one month till 16 June 2017, declining 4.27% compared with the Sensexs 1.55% rise. The scrip had also underperformed the market over the past one quarter declining 4.33% as against the Sensexs 4.97% rise. The scrip had, however, outperformed the market over the past one year advancing 72.14% as against the Sensexs 17.08% rise.

The small-cap company has equity capital of Rs 32 crore. Face value per share is Rs 10.

Shares of Deep Industries had rallied 11.41% in the preceding two trading sessions to settle at Rs 304.60 on Friday, 16 June 2017, from its closing of Rs 273.40 on 14 June 2017.

Deep Industries net profit spurted 81.2% to Rs 23.23 crore on 36.5% increase in net sales to Rs 74.90 crore in Q4 March 2017 over Q4 March 2016.

Deep Industries is engaged in business of oil and gas services, exploration and production.

Powered by Capital Market - Live News

Bank of Maharashtra skids after RBI initiates corrective action
Jun 19,2017

The announcement was made on Saturday, 17 June 2017.

Meanwhile, the S&P Sensex was up 157.22 points, 0.51% at 31,208.16. The S&P BSE Mid-cap index was up 20.66 points or 0.14% at 14,827.99.

On the BSE, 37,021 shares were traded on the counter so far as against the average daily volumes of 83,629 shares in the past one quarter. The stock had hit a high of Rs 30.50 and a low of Rs 29.60 so far during the day.

The stock had hit a 52-week high of Rs 40.70 on 4 May 2017 and a 52-week low of Rs 25 on 9 November 2016.

The stock had underperformed the market over the past one month till 16 June 2017, falling 9% compared with 1.55% rise in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 4.49% as against Sensexs 4.97% gains. The scrip had also underperformed the market in past one year, gaining 0.33% as against Sensexs 17.08% gains.

The mid-cap bank has equity capital of Rs 1168.33 crore. Face value per share is Rs 10.

Bank of Maharashtra said that the action will not have any material impact on the performance of the bank and it will contribute to improve the internal controls of the bank and improvement in its asset quality, profitability and efficiency.

The banks ratio of gross NPAs to gross advances stood at 16.93% as on 31 March 2017 as against 9.34% as on 31 March 2016. The ratio of net NPAs to net advances stood at 11.76% as on 31 March 2017 as against 6.35% as on 31 March 2016.

Bank of Maharashtra reported net loss of Rs 455.45 crore in Q4 March 2017 compared with net loss of Rs 119.84 crore in Q4 March 2016. Total income fell 5.9% to Rs 3354.80 crore in Q4 March 2017 over Q4 March 2016.

The Government of India (GoI) held 81.61% stake in Bank of Maharashtra (as per the shareholding pattern as on 31 March 2017).

Powered by Capital Market - Live News

Monnet Ispat tumbles 25% in four sessions
Jun 19,2017

Meanwhile, the S&P BSE Sensex was up 152.20 points or 0.49% at 31,208.60. The S&P BSE Small-Cap index rose 17.71 points or 0.11% at 15,684.95.

On the BSE, 3.30 lakh shares were traded on the counter so far as against the average daily volumes of 1.11 lakh shares in the past one quarter. The stock had hit a high of Rs 34 and a low of Rs 27.50 so far during the day. The stock had hit a 52-week high of Rs 44.50 on 17 May 2017 and a 52-week low of Rs 19.25 on 9 December 2016.

The stock had underperformed the market over the past one month till 16 June 2017, sliding 21.22% compared with the Sensexs 1.55% rise. The stock had also underperformed the market over the past one quarter, declining 1.01% as against the Sensexs 4.97% rise. The scrip had, however, outperformed the market over the past one year, advancing 45.55% as against the Sensexs 17.08% rise.

The small-cap company has equity capital of Rs 200.77 crore. Face value per share is Rs 10.

Shares of Monnet Ispat & Energy have declined 25.09% in four trading sessions to its ruling market price, from its closing of Rs 38.45 on 13 June 2017 on media reports that the company has filed for bankruptcy.

Meanwhile, Monnet Ispat in a clarification issued to the stock exchanges after market hours on Friday, 16 June 2017 with regard to aforesaid media reports said that it has not filed for bankruptcy. The reference of Monnet Ispat & Energy in the article is with reference to Gupta Coal, which has filed for bankruptcy and also supplied coal to Monnet Ispat & Energy at some point of time, the company said.

Therefore, the provisions of Regulation 30 of Listing Regulations, 2015 do not apply on the company, with respect to the aforesaid news item, Monnet Ispat said.

Monnet Ispat & Energy reported net loss of Rs 459.52 crore in Q4 March 2017, higher than net loss of Rs 438.65 crore in Q4 March 2016. Net sales declined 6.7% to Rs 348.27 crore in Q4 March 2017 over Q4 March 2016.

Monnet Ispat & Energy operates in two segments viz. power and steel.

Powered by Capital Market - Live News

L&T gets stronger after winning orders
Jun 19,2017

The announcement was made before market hours today, 19 June 2017.

Meanwhile, the S&P BSE Sensex was up 136.26 points, or 0.44%, to 31,192.66.

On the BSE, 16,212 shares were traded in the counter so far, compared with average daily volume of 1.96 lakh shares in the past one quarter. The stock had hit a high of Rs 1,752 and a low of Rs 1,732.05 so far during the day. The stock had hit a 52-week high of Rs 1,834 on 30 May 2017. The stock had hit a 52-week low of Rs 1,295.30 on 9 November 2016.

The stock had underperformed the market over the past one month till 16 June 2017, falling 1.06% compared with 1.55% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 10.1% as against Sensexs 4.97% gains. The scrip had also outperformed the market in past one year, gaining 15.75% as against Sensexs 17.08% gains.

The large-cap engineering & construction major has equity capital of Rs 186.68 crore. Face value per share is Rs 2.

Separately, the company on Saturday, 17 June 2017, clarified that it has not cancelled any corporate action. As informed earlier, dividend of Rs 21 per share will be paid on 24 August 2017 and bonus issue of 1:2 will be credited on or before 28 July 2017, record date of which was fixed as 14 July 2017. Both the corporate action is subject to approval of the shareholders.

The company issued the clarification after shareholders who are clients of ICICI Direct.com received emails from it about cancellation of dividend corporate action of L&T.

L&Ts consolidated net profit rose 28.1% to Rs 3180.41 crore on 12% increase in net sales to Rs 36827.99 crore in Q4 March 2017 over Q4 March 2016.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services.

Powered by Capital Market - Live News

Nucleus Software advances as after fixing record date for buyback of shares
Jun 19,2017

The announcement was made after market hours on Friday, 16 June 2017.

Meanwhile, the S&P BSE Sensex was up 127.59 points, or 0.41% at 31,183.99. The S&P BSE Small-cap index was up 13.43 points, or 0.09% at 15,680.67.

On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 22,814 shares in the past one quarter. The stock had hit a high of Rs 342 and a low of Rs 335.95 so far during the day. The stock had hit a 52-week high of Rs 343.90 on 22 May 2017 and a 52-week low of Rs 171 on 29 September 2016.

The stock had underperformed the market over the past one month till 16 June 2017, sliding 0.15% compared with the Sensexs 1.55% rise. The scrip had, however, outperformed the market over the past one quarter advancing 32.3% as against the Sensexs 4.97% rise. The scrip had also outperformed the market over the past one year advancing 63.17% as against the Sensexs 17.08% rise.

The small-cap company has equity capital of Rs 32.38 crore. Face value per share is Rs 10.

Nucleus Software Exports said that the buyback committee of the board at its meeting held on Friday, 16 June 2017 has fixed 30 June 2017 as the record date for the buyback of equity shares. The board has approved buyback of upto 33.43 lakh equity shares representing upto 10.32% of the total paid-up equity share capital of the company. The buyback price is Rs 350 per share for an aggregate amount not exceeding Rs 117 crore which is 24.83% of the paid-up equity share capital and free reserves of the company for the financial year ended 31 March 2017.

Nucleus Software Exports consolidated net profit rose 39.82% to Rs 22.26 crore on 0.59% increase in net sales to Rs 93.69 crore in Q4 March 2017 over Q3 December 2016.

Nucleus Software Exports is the leading provider of lending and transaction banking products to the global financial services industry.

Powered by Capital Market - Live News

Nucleus Software advances after fixing record date for buyback of shares
Jun 19,2017

The announcement was made after market hours on Friday, 16 June 2017.

Meanwhile, the S&P BSE Sensex was up 127.59 points, or 0.41% at 31,183.99. The S&P BSE Small-cap index was up 13.43 points, or 0.09% at 15,680.67.

On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 22,814 shares in the past one quarter. The stock had hit a high of Rs 342 and a low of Rs 335.95 so far during the day. The stock had hit a 52-week high of Rs 343.90 on 22 May 2017 and a 52-week low of Rs 171 on 29 September 2016.

The stock had underperformed the market over the past one month till 16 June 2017, sliding 0.15% compared with the Sensexs 1.55% rise. The scrip had, however, outperformed the market over the past one quarter advancing 32.3% as against the Sensexs 4.97% rise. The scrip had also outperformed the market over the past one year advancing 63.17% as against the Sensexs 17.08% rise.

The small-cap company has equity capital of Rs 32.38 crore. Face value per share is Rs 10.

Nucleus Software Exports said that the buyback committee of the board at its meeting held on Friday, 16 June 2017 has fixed 30 June 2017 as the record date for the buyback of equity shares. The board has approved buyback of upto 33.43 lakh equity shares representing upto 10.32% of the total paid-up equity share capital of the company. The buyback price is Rs 350 per share for an aggregate amount not exceeding Rs 117 crore which is 24.83% of the paid-up equity share capital and free reserves of the company for the financial year ended 31 March 2017.

Nucleus Software Exports consolidated net profit rose 39.82% to Rs 22.26 crore on 0.59% increase in net sales to Rs 93.69 crore in Q4 March 2017 over Q3 December 2016.

Nucleus Software Exports is the leading provider of lending and transaction banking products to the global financial services industry.

Powered by Capital Market - Live News

Suprajit Engg advances on fund buying
Jun 19,2017

Meanwhile, the S&P BSE Sensex was up 129.48 points or 0.42% at 31,185.88. The S&P BSE Small-Cap index advanced 12.80 points or 0.08% at 15,680.04.

On the BSE, 2,446 shares were traded on the counter so far as against the average daily volumes of 32,021 shares in the past one quarter. The stock had hit a high of Rs 303.80 so far during the day, which is a record high. The stock hit a low of Rs 299 so far during the day. The stock had hit a 52-week low of Rs 170 on 24 June 2016.

The stock had outperformed the market over the past one month till 16 June 2017, advancing 17.98% compared with the Sensexs 1.55% rise. The stock had also outperformed the market over the past one quarter, gaining 35.46% as against the Sensexs 4.97% rise. The scrip had also outperformed the market over the past one year, advancing 61.44% as against the Sensexs 17.08% rise.

The small-cap company has equity capital of Rs 13.13 crore. Face value per share is Rs 1.

On consolidated basis, Suprajit Engineerings net profit rose 134.7% to Rs 40.41 crore on 32% growth in net sales to Rs 361.50 crore in Q4 March 2017 over Q4 March 2016.

Suprajit Engineering is one of the leading manufacturers of automotive cables in India.

Powered by Capital Market - Live News

NTPC brightens after commissioning further capacity of solar project
Jun 19,2017

The announcement was made after market hours on Friday, 16 June 2017.

Meanwhile, the S&P BSE Sensex was up 166.21 points or 0.54% at 31,222.61.

On the BSE, 13,837 shares were traded on the counter so far as against the average daily volumes of 3.52 lakh shares in the past one quarter. The stock had hit a high of Rs 161.60 and a low of Rs 160.60 so far during the day.

The stock had hit a 52-week high of Rs 177.80 on 27 January 2017 and a 52-week low of Rs 139.70 on 15 July 2016.

The stock had underperformed the market over the past one month till 16 June 2017, rising 0.31% compared with 1.55% rise in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 0.47% as against Sensexs 4.97% gains. The scrip had underperformed the market in past one year, gaining 5.6% as against Sensexs 17.08% gains.

The large-cap company has equity capital of Rs 8245.46 crore. Face value per share is Rs 10.

NTPC said that with this commissioning, the installed capacity of NTPCs solar power projects has become 845 megawatts (MW). The total installed capacity of NTPC on standalone basis has become 44,419 MW and that of NTPC group has become 51,635 MW.

On 2 June 2017, NTPC had commissioned 117 MW out of 250 MW of Mandsaur Solar Power Project.

NTPCs net profit declined 25.5% to Rs 2079.40 crore on 11.4% rise in net sales to Rs 20416.67 crore in Q4 March 2017 over Q4 March 2016.

NTPC, Indias largest power company, has presence in the entire value chain of power generation business. The government of India held 69.75% stake in the firm as on 31 March 2017, as per the shareholding pattern.

Powered by Capital Market - Live News

Dr Reddys Lab drops after receiving Form 483 for plant
Jun 19,2017

The announcement was made after market hours on Friday, 16 June 2017.

Meanwhile, the S&P BSE Sensex was up 150.97 points or 0.49% at 31,207.37.

On the BSE, 5,666 shares were traded on the counter so far as against the average daily volumes of 39,467 shares in the past one quarter. The stock had hit a high of Rs 2,677.10 and a low of Rs 2,647 so far during the day. The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,382.05 on 29 May 2017.

The stock had underperformed the market over the past one month till 16 June 2017, sliding 1.69% compared with the Sensexs 1.55% rise. The stock had also underperformed the market over the past one quarter, declining 2.73% as against the Sensexs 4.97% rise. The scrip had also underperformed the market over the past one year, declining 12.14% as against the Sensexs 17.08% rise.

The large-cap company has equity capital of Rs 82.89 crore. Face value per share is Rs 5.

Dr Reddys Laboratories announced that the audit of its Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, by the United States Food and Drug Administration (USFDA), has been completed on 16 June 2017. The company has been issued a Form 483 with one observation, which it is addressing.

Dr Reddys Laboratories consolidated net profit rose 175.4% to Rs 337.60 crore on 5.4% decline in net sales to Rs 3554.20 crore in Q4 March 2017 over Q4 March 2016.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Tata Steel hardens after plans to sell shares in Tata Motors
Jun 19,2017

The announcement was made on Saturday, 17 June 2017.

Shares of Tata Motors declined 0.09% to Rs 455.10.

Meanwhile, the S&P BSE Sensex was up 137.68 points or 0.44% at 31,194.08.

On the BSE, 43,890 shares were traded on the counter so far of Tata Steel as against the average daily volumes of 8.08 lakh shares in the past one quarter. The stock had hit a high of Rs 512.50 and a low of Rs 509 so far during the day.

Tata Steel said that the transaction is expected to be executed on or after 23 June 2017 at or around the prevailing price on the date of proposed sale, subject to no material market movements in price since the date of this disclosure.

Tata Sons is the promoter of the major operating Tata companies and holds significant shareholdings in these companies. Tata companies are commonly referred to as the Tata group and the Chairman of Tata Sons as Chairman of the Tata group.

About 66% of the equity capital of Tata Sons is held by philanthropic trusts endowed by members of the Tata family. The largest of these trusts are the Sir Dorabji Tata Trust and the Sir Ratan Tata Trust, which were created by the sons of Jamsetji Nusserwanji Tata, the founder of the group.

Tata Steel held 2.9% stake while Tata Sons held 28.71% stake in Tata Motors, as per the shareholding pattern as on 31 March 2017.

Tata Steel reported consolidated net loss of Rs 1168.02 crore in Q4 March 2017, compared with net loss of Rs 3041.88 crore in Q4 March 2016. The consolidated net sales rose 29.6% to Rs 33424.09 crore in Q4 March 2017 over Q4 March 2016.

Tata Steel is the worlds second-most geographically-diversified steel producer, with operations in 26 countries and commercial presence in over 50 countries.

Powered by Capital Market - Live News

Jayant Agro-Organics spurts after board recommends bonus issue
Jun 16,2017

The announcement was made during trading hours today, 16 June 2017.

Meanwhile, the S&P BSE Sensex was down 33.80 points, or 0.11% to 31,041.93.

On the BSE, 64,000 shares were traded in the counter so far, compared with average daily volumes of 11,912 shares in the past one quarter. The stock had hit a high of Rs 1,038 so far during the day, which is also a record high for the counter. The stock had hit a low of Rs 980 so far during the day. The stock hit a 52-week low of Rs 203.50 on 16 June 2016.

The stock had underperformed the market over the past one month till 15 June 2017, falling 0.79% compared with 1.36% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 50.09% as against Sensexs 4.81% rise. The scrip had also outperformed the market in past one year, rising 369.68% as against Sensexs 17.15% rise.

The small-cap company has equity capital of Rs 7.50 crore. Face value per share is Rs 5.

Jayant Agro-Organics said the recommendation to issue bonus shares is subject to the approval of shareholders of the company at the annual general meeting.

Further, the board also recommended raising upto Rs 250 crore through issue of securities on private placement basis.

Jayant Agro-Organics consolidated net profit surged 94.88% to Rs 15.59 crore on 12.71% growth in net sales to Rs 420.56 crore in Q4 March 2017 over Q4 March 2016.

Jayant Agro-Organics is an emerging global oleochemical company with leadership in the castor-based specialty chemicals industry.

Powered by Capital Market - Live News

Volumes jump at Ipca Laboratories counter
Jun 16,2017

Ipca Laboratories clocked volume of 6.87 lakh shares by 14:20 IST on BSE, a 135.42-times surge over two-week average daily volume of 5,000 shares. The stock slumped 9.84% to Rs 462.65 after the company said that drugs manufactured at its facilities at SEZ Indore (Pithampur), Piparia (Silvassa) and Ratlam (Madhya Pradesh) have been banned from the US market by the US Food and Drug Administration (USFDA). The drug regulator cited violation of current good manufacturing norms for taking the step against the company. The announcement was made after market hours yesterday, 15 June 2017.

Vesuvius India notched up volume of 70,000 shares, a 20.88-fold surge over two-week average daily volume of 3,000 shares. The stock declined 1.23% to Rs 1,260.

HDFC saw volume of 20 lakh shares, a 12.03-fold surge over two-week average daily volume of 1.66 lakh shares. The stock rose 0.49% to Rs 1,645.85.

Torrent Pharmaceuticals clocked volume of 1.03 lakh shares, a 11.96-fold surge over two-week average daily volume of 9,000 shares. The stock fell 2.07% to Rs 1,210.80.

Aban Offshore saw volume of 16.88 lakh shares, a 11.93-fold rise over two-week average daily volume of 1.42 lakhs shares. The stock jumped 11.73% to Rs 194.35.

Powered by Capital Market - Live News

DFM Foods recovers after recent sharp slide
Jun 16,2017

Meanwhile, the S&P BSE Sensex was up 31.04 points, or 0.1% at 31,106.77. The S&P BSE Small-Cap index was up 51.30 points, or 0.33% at 15,697.19.

High volumes were traded on the counter. On the BSE, 2,908 shares were traded on the counter so far as against the average daily volumes of 2,454 shares in the past one quarter. The stock had hit a high of Rs 1,299 and a low of Rs 1,205.95 so far during the day. The stock had hit a record high of Rs 2,433.60 on 17 June 2016 and a 52-week low of Rs 1,122 on 7 June 2017.

The stock had underperformed the market over the past one month till 15 June 2017, declining 28.12% compared with the Sensexs 2.49% rise. The scrip had also underperformed the market over the past one quarter declining 30.79% as against the Sensexs 5.71% rise. The scrip had also underperformed the market over the past one year declining 47.7% as against the Sensexs 16.27% rise.

The small-cap company has equity capital of Rs 10 crore. Face value per share is Rs 10.

Shares of DFM Foods had declined 11.52% in the preceding five trading sessions to settle at Rs 1,202.15 yesterday, 15 June 2017, from its close of Rs 1,358.70 on 8 June 2017.

DFM Foods net profit fell 68.5% to Rs 3.66 crore on 24.2% decrease in net sales to Rs 93.17 crore in Q4 March 2017 over Q4 March 2016.

DFM Foods is engaged in manufacturing and marketing of snack foods.

Powered by Capital Market - Live News

Pharma stocks witness selling pressure
Jun 16,2017

IPCA Laboratories (down 11.22%), Lupin (down 4.23%), Divis Laboratories (down 2.25%), Cadila Healthcare (down 2.14%), Cipla (down 1.78%), Sun Pharmaceutical Industries (down 1.75%), Dr Reddys Laboratories (down 1.23%), Strides Shasun (down 0.97%), Piramal Enterprises (down 0.56%) and Wockhardt (down 0.07%), edged lower. Glenmark Pharmaceuticals (up 0.31%), Alkem Laboratories (up 0.41%), GlaxoSmithKline Pharmaceuticals (up 0.75%) and Aurobindo Pharma (up 1.76%), edged higher.

The S&P BSE Sensex was up 34.56 points, or 0.11% at 31,110.29.

According to media reports, US President Donald Trumps administration is preparing an executive order aimed at lowering US drug costs. Officials in the administration will meet later today, 16 June 2017.

One policy being discussed for inclusion in the order is expressing support for value-based agreements, a drug industry-backed proposal in which pharmaceutical companies and health insurers develop arrangements to pay for products depending on how well they work, reports added.

A domestic brokerage reportedly said that this move could further create pricing pressure and hurt Indian pharma companies that are already facing regulatory issues and currency woes. The broker continued to remain cautious on the sector, reports added.

Powered by Capital Market - Live News

Aban Offshore leads gainers on BSEs A group
Jun 16,2017

Aban Offshore rose 12.96% at Rs 196.50. The stock topped the gainers in A group. On the BSE, 14.88 lakh shares were traded on the counter so far as against the average daily volumes of 1.42 lakh shares in the past two weeks.

Firstsource Solutions rose 5.56% at Rs 32.25. The stock was the second biggest gainer in A group. On the BSE, 5.04 lakh shares were traded on the counter so far as against the average daily volumes of 4.16 lakh shares in the past two weeks.

VA Tech Wabag rose 5.46% at Rs 727. The stock was the third biggest gainer in A group. On the BSE, 54,000 shares were traded on the counter so far as against the average daily volumes of 7,798 shares in the past two weeks.

GVK Power & Infrastructure rose 5% at Rs 6.30. The stock was the fourth biggest gainer in A group. On the BSE, 12.15 lakh shares were traded on the counter so far as against the average daily volumes of 11 lakh shares in the past two weeks.

Gujarat Mineral Development Corporation (GMDC) rose 4.97% at Rs 153. The stock was the fifth biggest gainer in A group. On the BSE, 1 lakh shares were traded on the counter so far as against the average daily volumes of 1.69 lakh shares in the past two weeks.

Powered by Capital Market - Live News